Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
OraSure Technologies has reported Q2 earnings per share at $0.09, which has decreased by 80.85% compared to Q1, which was 0.47. Assertio Holdings saw a decrease in earnings per share from 0.29 in Q1 to $0.19 now. CalciMedica's earnings per share for Q2 sits at $-1.11, whereas in Q1, they were at -0.48. This quarter, Quoin Pharmaceuticals experienced an increase in earnings per share, which was $-4.08 in Q1 and is now $-2.13. Most recently, First Wave BioPharma reported earnings per share at $-1.89, whereas in Q1 earnings per share sat at $-1.82.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.